A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2002
11/21/2002	CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	CA2446605A1 Novel processes for the preparation of adenosine compounds and intermediates thereto
11/21/2002	CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	CA2443964A1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
11/21/2002	CA2443191A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/20/2002	EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002	EP1258476A1 Alpha-amino acid derivatives, method for their preparation and their use as dipeptidyl-peptidase IV inhibitors (DPP IV)
11/20/2002	EP1258253A1 Novel remedies with the use of beta3 agonist
11/20/2002	EP1258249A1 Oral preparations for diabetes
11/20/2002	EP1258247A1 Adenosine analogues for the treatment of insulin resistance syndrome and diabetes
11/20/2002	EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002	EP1257646A2 Transporters and ion channels
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257572A2 Narc-1, subtilase-like homologs
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1257541A2 Polypharmacophoric agents
11/20/2002	EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257528A1 Aminoalcohol derivatives
11/20/2002	EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002	EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002	EP1257304A1 Foam-forming wound dressing
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	EP1257277A2 New drug combinations comprising a norepinephrine reuptake inhibitor and an antimuscarinic agent
11/20/2002	EP1257272A1 Thiazolium compounds and treatments of disorders associated with protein aging
11/20/2002	EP1257270A1 A method for synthesizing leflunomide
11/20/2002	EP1257267A1 Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms
11/20/2002	EP1257264A1 Estrogen receptor modulators
11/20/2002	EP1257263A2 Microcompetiton and human disease
11/20/2002	EP1140190B1 Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indications
11/20/2002	EP1077966B1 Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/20/2002	EP1001758B1 Method of screening of potential drugs against obesity, capable of modulating the regulation of ucp-2
11/20/2002	EP0984952B1 A new salt
11/20/2002	EP0946189B1 Use of cntf (ciliary neurotrophic factor) receptor activators for the treatment of obesity
11/20/2002	EP0935469B1 Use of growth hormone
11/20/2002	EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002	EP0845992B1 Use of relaxin for promoting angiogenesis
11/20/2002	EP0776325B1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same
11/20/2002	EP0547151B1 Treatment process for promoting weight loss employing a substituted delta 5-androstene
11/20/2002	CN1380902A Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
11/20/2002	CN1380885A Alginate having low molecular weight, method of manufacturing it and its use
11/20/2002	CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002	CN1380304A N-terminal deletion lipocyte complement related protein and its preparation method
11/20/2002	CN1380302A Triterpene compound concentrate
11/20/2002	CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/20/2002	CN1380276A Method for converting derivative of internal inositol of buckwheat seed into its monomer and its seed
11/20/2002	CN1380105A Biological preparation medicine modulated by micro-alternating biological electric field for curing diabetes and its production method
11/20/2002	CN1380096A Nokemei capsule and its production method
11/20/2002	CN1380072A Medicine for curing diabetes and other metabolic disease
11/20/2002	CN1380070A Chinese medicine for curing diabetes
11/20/2002	CN1380067A Medicine with functions of reducing sugar and reducing blood-fat and its preparation method
11/20/2002	CN1380065A Trace element preparation for livestock and fowl and its preparation method
11/20/2002	CN1380058A Medicine for promoting synthesis of human self-body EPA and DHA
11/20/2002	CN1094358C Hypoglycemic medicine composition
11/20/2002	CN1094352C Composition for treating and preventing sudden death of chicken
11/20/2002	CN1094348C Compound multiple vitamin drop for infant
11/20/2002	CN1094313C 饱腹食品 Satiating food
11/19/2002	US6482951 Isoindolin-1-one glucokinase activators
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482830 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
11/19/2002	US6482822 N-(iminomethyl)amines derivatives, their preparation, their use as medicines and compositions containing them
11/19/2002	US6482812 Method of locking 1α-OH of vitamin D compounds in axial orientation
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482612 Adipocyte-specific protein homologs
11/19/2002	US6482433 Instant foods, beverages
11/19/2002	US6482413 Vitamin B12 —biodegradable micro particulate conjugate carrier systems for peroral delivery of drugs, therapeutic peptides/proteins and vaccines
11/19/2002	CA2252513C Method for the prevention and treatment of cachexia and anorexia
11/19/2002	CA2236422C Hydrolysis-optimized lipid emulsions and use thereof
11/15/2002	WO2001090053A1 Diphenylmethane derivatives
11/15/2002	CA2409144A1 Diphenylmethane derivatives
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090559A1 A method for preparing lactic acid fermented solution of mushroom and lactic acid fermented solution of mushroom produced thereby
11/14/2002	WO2002090545A2 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002	WO2002090388A1 Derivatives of exendin
11/14/2002	WO2002090375A2 Liver x receptor agonists
11/14/2002	WO2002090355A1 N-aroyl cyclic amines
11/14/2002	WO2002090353A1 Sulfonamides
11/14/2002	WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002	WO2002090348A1 Sulfonamides
11/14/2002	WO2002090347A1 Amide compounds
11/14/2002	WO2002090337A1 Sulfonamides
11/14/2002	WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002	WO2002090326A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
11/14/2002	WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives

1 ... 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 ... 1298